• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NXS 4.84% 32.5¢

NEXT SCIENCE LIMITED

Next Science Limited is an Australia-based medical technology company. The Company’s... Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NXS 01/05/24 21 5.8K
01/05/24 Last post  256lith Comments Created with Sketch.  21  Views Created with Sketch.  5.8K 
NXS 30/04/24 0 177
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  177 
NXS
technical analysis chart
24/04/24 5 1.6K
24/04/24 Last post  Saragian Comments Created with Sketch.  5  Views Created with Sketch.  1.6K 
NXS
News: NXS Next Science Posts 1Q Direct Product Sales Of $4.3M
24/04/24 0 129
24/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  129 
NXS 23/04/24 1 546
23/04/24 Last post  2001aSO Comments Created with Sketch.  1  Views Created with Sketch.  546 
NXS 20/04/24 9 2.7K
20/04/24 Last post  Mangoman605 Comments Created with Sketch.  9  Views Created with Sketch.  2.7K 
NXS 18/04/24 5 1.2K
18/04/24 Last post  EllieC Comments Created with Sketch.  5  Views Created with Sketch.  1.2K 
NXS
Bell Potter fined in 2017 for price manipulation
16/04/24 35 12K
16/04/24 Last post  Montytheman Comments Created with Sketch.  35  Views Created with Sketch.  12K 

See All Discussions arrow Created with Sketch.

Timeline

Investor presentation
30 Apr 09:28
 
Appendix 4C & Quarterly Activity Report - 31 March 2024
24 Apr 08:02
 
Notice of 1Q FY24 Result and Investor Webinar
22 Apr 09:38
 
Publication of Dr. Harris XPERIENCE study
18 Apr 09:39
 
Preliminary results of further XPERIENCE studies released
17 Apr 08:27
 
Study published showing impact of XPERIENCE on SSIs
16 Apr 09:02
 
View More arrow Created with Sketch.
(20min delay)
Last
32.5¢
Change
0.015(4.84%)
Mkt cap ! $94.80M
Open High Low Value Volume
31.0¢ 32.5¢ 31.0¢ $3.532K 11.10K

Buyers (Bids)

No. Vol. Price($)
1 3049 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 4394 1
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
32.0¢
  Change
0.015 ( 1.59 %)
Open High Low Volume
32.0¢ 32.5¢ 32.0¢ 1381
Last updated 15.59pm 01/05/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.